BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 13, 2015
View Archived Issues
NO-donating bimatoprost shows preclinical efficacy reducing IOP
Read More
FDA designates Cidara's CD-101 IV as QIDP
Read More
Lilly and BioNTech form cancer immunotherapy collaboration
Read More
NAPs show promising sequence-independent antiviral activity
Read More
Retrophin introduces compounds for the treatment of neurodegeneration
Read More
Roche patents CYP11B2 inhibitors
Read More
Astellas to access Cyclenium's macrocycle drug discovery technologies
Read More
Roivant Sciences licenses nelotanserin from Arena Pharmaceuticals
Read More
Sumitomo Dainippon Pharma profiles progress of fourth quarter of fiscal 2014
Read More
Celprogen reveals pancreatic stem cell stimulator STEMC-7007
Read More
Data on REGN-844 for dry eye disease reported
Read More
PIM-447 shows potential for the treatment of MM
Read More
Merck & Co. discloses ROM-K channel blockers
Read More
Michael J. Fox Foundation acquires research tools from Imago
Read More
Dana-Farber, Syros Pharmaceuticals and Paraza Pharma jointly patent CDK7 inhibitors
Read More
Evofosfamide receives FDA fast track designation for pancreatic cancer
Read More
Shionogi prepares and tests ACC2 inhibitors
Read More
Astellas Pharma discloses GABA(B) positive allosteric modulators
Read More
Intravitreal CD34+ autologous bone marrow-derived cells safe in dry AMD patients
Read More
MorphoSys completes acquisition of Lanthio Pharma
Read More
FDA advisory committee recommends approval of Orkambi for cystic fibrosis
Read More
Preliminary phase I results of Ebola prime-boost vaccine regimen of MVA-BN Filo and AdVac
Read More
Takeda terminates phase III trial of alisertib in peripheral T-cell lymphoma
Read More
Fibrocell's FCX-007 receives rare pediatric disease designation from the FDA
Read More
FDA awards orphan drug designation to SemiAlloGen's approach to targeting glioblastoma
Read More
